Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press ...

CG Oncology (NASDAQ:CGON) is up ~7% in Monday trading as the company's candidate for a type of bladder cancer is seen as ...

About Renovaro Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted ...

NEW YORK, NY, UNITED STATES, September 12, 2024 /EINPresswire / -- OBiS, a New York City-based healthcare analytics consulting firm, has developed a pre-meeting report based on the abstract titles ...

today announced four abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2024, which convenes in Barcelona, Spain, from September 13-17 ...

Latest data of InnoCare’s (HKEX: 09969; SSE: 688428) orelabrutinib were presented at the European Society for Medical Oncology (ESMO) Congress 2024. A Prospective Study of Orelabrutinib plus ...

CEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress Data to be presented on Saturday, September 14 and published ...

today announced a poster presentation at the upcoming 2024 European Society for Medical Oncology (ESMO) Annual Meeting to be held in Barcelona, Spain from September 13–17, 2024. Title ...

While the savings are substantial, they will not by themselves solve European ... from IQVIA on oncology and hematology please click here. For the sixth year running the PM Society will be ...

Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress ...

About ESMO ESMO is the European Society for Medical Oncology. Representing more than 35,000 oncology professionals in 172 countries, ESMO is a reference for oncology education and information.